OncoMed Pahrmaceuticals, Inc.
|OncoMed Pahrmaceuticals, Inc. Patent applications|
|Patent application number||Title||Published|
|20130316450||Compositions and Methods for Diagnosing and Treating Cancer - Isolated antibodies that specifically bind the human MET Receptor and inhibit MET signaling are described. Also described are methods of treating cancer, the methods comprising administering a therapeutically effective amount of the provided MET antibodies and combinations thereof.||11-28-2013|